South Korea Iron Deficiency Anemia Therapy Market to 2032
Overview
The South Korea Iron Deficiency Anemia Therapy Market is expected to reach a 135.79 USD Million by 2032 and is projected to grow at a CAGR of 10.56% from 2025 to 2032.
Revenue, 2024 (USD Million)
67.24
Forecast, 2032 (USD Million)
135.79
CAGR, 2024 - 2032
10.56%
Report Coverage
South Korea
South Korea Iron Deficiency Anemia Therapy Market 2018-2032 USD Million
South Korea Iron Deficiency Anemia Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 67.24 USD Million
- Projected Market Size (2032): 135.79 USD Million
- CAGR (2025-2032): 10.56%
Key Findings of South Korea Iron Deficiency Anemia Therapy Market
- The South Korea Iron Deficiency Anemia Therapy Market was valued at 67.24 USD Million in 2024.
- The South Korea Iron Deficiency Anemia Therapy Market is likely to grow at a CAGR of 10.56% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral Iron Therapy in Therapy Segment accounted for the largest share of the market with a revenue of 40.20 USD Million
- The fastest growing segment Obstetrics and Gynecology in Therapy Area Segment grew Fastest with a CAGR of 11.34% during the forecast period from 2024 to 2032.
South Korea Iron Deficiency Anemia Therapy Market Scope
South Korea Iron Deficiency Anemia Therapy Market Segmentation & Scope
Distribution Channel
- Online Pharmacies
- Drug Stores and Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Home Care Setting
- Specialty Clinics
- Hospitals
Population
- Pediatric
- Geriatric
- Adults
Therapy Area
- Inflammatory Bowel Disease
- Oncology
- Congestive Heart Failure (CHF)
- Others
- Renal Diseases
- Obstetrics and Gynecology
Therapy
- Oral Iron Therapy
- Parenteral Iron Therapy
South Korea Iron Deficiency Anemia Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 67.24 USD Million |
| Market Value in 2032 | 135.79 USD Million |
| CAGR (2025-2032) | 10.56% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Population,Therapy Area,Therapy |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 67.24 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 170.79 USD Million in 2024.
Segments and Scope
-
South Korea Iron Deficiency Anemia Therapy Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a revenue of 39.32 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a Growth rate of 10.41 % in forecast period 2025-2032.
-
South Korea Iron Deficiency Anemia Therapy Market to 2032, By End User
- Hospitals is the largest segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a revenue of 39.79 USD Million in the year 2024.
- Home Care Setting is the Fastest growing segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a Growth rate of 10.41 % in forecast period 2025-2032.
-
South Korea Iron Deficiency Anemia Therapy Market to 2032, By Population
- Adults is the largest segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a revenue of 30.15 USD Million in the year 2024.
- Adults is the Fastest growing segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a Growth rate of 10.85 % in forecast period 2025-2032.
-
South Korea Iron Deficiency Anemia Therapy Market to 2032, By Therapy Area
- Obstetrics and Gynecology is the largest segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a revenue of 27.29 USD Million in the year 2024.
- Obstetrics and Gynecology is the Fastest growing segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a Growth rate of 11.34 % in forecast period 2025-2032.
-
South Korea Iron Deficiency Anemia Therapy Market to 2032, By Therapy
- Parenteral Iron Therapy is the largest segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a revenue of 40.20 USD Million in the year 2024.
- Parenteral Iron Therapy is the Fastest growing segment in South Korea Iron Deficiency Anemia Therapy Market to 2032 with a Growth rate of 10.70 % in forecast period 2025-2032.
South Korea Iron Deficiency Anemia Therapy Market Company Share Analysis
| Company Name |
|
||
| Pfizer Inc. | |||
| Sanofi | |||
| DAIICHI SANKYO COMPANY, LIMITED | |||
| CSL | |||
| AFT Pharmaceuticals | |||
South Korea Iron Deficiency Anemia Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Iron Deficiency Anemia Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Iron Deficiency Anemia Therapy Market is segmented based on Segmentation Distribution Channel,End User,Population,Therapy Area,Therapy.
South Korea Iron Deficiency Anemia Therapy Market was valued at USD 67.24(Revenue in USD Million) in 2023.
South Korea Iron Deficiency Anemia Therapy Market is projected to grow at a CAGR of 10.56% during the forecast period of 2024 to 2032.
The Parenteral Iron Therapy segment is expected to dominate the South Korea Iron Deficiency Anemia Therapy Market, holding a largest market share of 40.20 USD Million in 2024
South Korea Iron Deficiency Anemia Therapy Market Scope
South Korea Iron Deficiency Anemia Therapy Market Segmentation & Scope
Distribution Channel
- Online Pharmacies
- Drug Stores and Retail Pharmacies
- Hospital Pharmacy
End User
- Others
- Home Care Setting
- Specialty Clinics
- Hospitals
Population
- Pediatric
- Geriatric
- Adults
Therapy Area
- Inflammatory Bowel Disease
- Oncology
- Congestive Heart Failure (CHF)
- Others
- Renal Diseases
- Obstetrics and Gynecology
Therapy
- Oral Iron Therapy
- Parenteral Iron Therapy
Frequently Asked Questions
The South Korea Iron Deficiency Anemia Therapy Market is segmented based on Segmentation Distribution Channel,End User,Population,Therapy Area,Therapy.
South Korea Iron Deficiency Anemia Therapy Market was valued at USD 67.24(Revenue in USD Million) in 2023.
South Korea Iron Deficiency Anemia Therapy Market is projected to grow at a CAGR of 10.56% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Iron Deficiency Anemia Therapy Market for final year is USD 135.79 (USD Million).
South Korea Iron Deficiency Anemia Therapy Market Company Profiling
Frequently Asked Questions
The South Korea Iron Deficiency Anemia Therapy Market is segmented based on Segmentation Distribution Channel,End User,Population,Therapy Area,Therapy.
South Korea Iron Deficiency Anemia Therapy Market was valued at USD 67.24(Revenue in USD Million) in 2023.
South Korea Iron Deficiency Anemia Therapy Market is projected to grow at a CAGR of 10.56% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Iron Deficiency Anemia Therapy Market for final year is USD 135.79 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.